Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Antony
Clinical trial register · France

Clinical Trials in Antony, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9714 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:18 UTC
9714
Studies in scope
all four open statuses
6038
Recruiting now
open to new participants
1027
Lead sponsors
across recruiting studies
Top sites
Paris 2842 Lyon 1396 Bordeaux 1391 Marseille 1288 Lille 1281
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sanofi4 Novartis Pharmaceuticals3 Federation Francophone de Cancerologie Digestive3 Incyte Corporation2 Gustave Roussy, Cancer Campus, Grand Paris1 LEO Pharma1 Fondation Ellen Poidatz1 GCS Ramsay Santé pour l'Enseignement et la Recherche1 Institut National de la Santé Et de la Recherche Médicale, France1 Biogen1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 AbbVie1 AstraZeneca1 Mitral1 Pfizer1 Janssen Research & Development, LLC1 Imagine Institute1 Intergroupe Francophone de Cancerologie Thoracique1 Regeneron Pharmaceuticals1 Institut Curie1 BeOne Medicines1
Site location
Paris2842 Lyon1396 Bordeaux1391 Marseille1288 Lille1281 Montpellier1014 Toulouse1012 Nantes913 Dijon816 Angers775 Nice768 Clermont-Ferrand750 Brest729 Caen724 Strasbourg675 Amiens621 Villejuif569 Créteil560 Besançon554 Bron551 Rennes535 Grenoble514 Rouen388 Poitiers350 Pierre-Bénite344 Show all 803
All 803 locations
Target enrolment
to

Trials with a site in Antony

29 of 9714 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Cohort of Patients With Chronic Myelomonocytic Leukemia
NCT07512882Leukemia, Myelomonocytic Leukemia, Chronic
Gustave Roussy, Cancer Campus, Grand Paris
Observational
5,000
Amiens, Angers, Antony, Bobigny, Corbeil-Essonnes, Grenoble, Le Kremlin-Bicêtre, Lille
2026-05-05
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Observational
100
Antony
2026-01-14
Active, closed
Novartis Pharmaceuticals
Phase 2
34
Antony, Dijon, Martigues, Nice
2025-11-10
Recruiting
Sanofi
Phase 2
208
Antony, Bezannes, Bordeaux, Lyon, Saint-Priest-en-Jarez, Toulouse
2025-11-06
Not yet open
Federation Francophone de Cancerologie Digestive
Phase 2
300
Angers, Annecy, Antony, Aurillac, Bayeux, Bayonne, Beauvais, Besançon
2025-08-31
Recruiting
Incyte Corporation
Phase 3
600
Antony, Bordeaux, Brest, Créteil, Lyon, Marseille, Nantes, Nice
2025-02-28
Recruiting
LEO Pharma
Phase 3
90
Antony, Lyon, Nice, Paris
2025-02-05
Recruiting
Fondation Ellen Poidatz
Not applicable
10
Antony, Saint-Fargeau-Ponthierry
2024-11-12
Recruiting
Institut Curie
Not applicable
60
Antony, Paris, Saint-Cloud, Saint-Mandé, Suresnes
2024-10-14
Active, closed
Incyte Corporation
Phase 3
349
Antony, Brest, Martigues, Mulhouse, Nantes, Paris, Romans-sur-Isère, Toulouse
2024-10-10
Active, closed
Novartis Pharmaceuticals
Observational
192
Nice, Antony, Bordeaux, Brest, Calais, Dijon, La Rochelle, Le Mans
2024-06-17
Active, closed
Sanofi
Phase 3
1,541
Antony, Nice, Paris, Pierre-Bénite, Reims, Romans-sur-Isère, Rouen, Toulouse
2024-05-08
Recruiting
Mitral
Not applicable
500
Aix-en-Provence, Antony, Bordeaux, Montpellier, Mulhouse, Paris, Reims, Roanne
2024-03-26
Recruiting
Federation Francophone de Cancerologie Digestive
Phase 3
310
Agen, Aix-en-Provence, Amiens, Antony, Argenteuil, Arras, Aurillac, Auxerre
2024-02-26
Active, closed
Regeneron Pharmaceuticals
Phase 1/2
148
Poitiers, Lille, Montpellier, Paris, Antony, Villejuif
2023-12-19
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Amiens, Antony, Arras, Avignon, Bayonne, Besançon, Bordeaux, Bourg-en-Bresse
2023-10-24
Active, closed
Janssen Research & Development, LLC
Phase 3
684
Antony, Argenteuil
2023-10-12
Active, closed
PRostate Olaparib Real World Evidence Study
NCT06031805Metastatic Castration-resistant Prostate Cancer
AstraZeneca
Observational
159
Amiens, Angers, Antony, Argenteuil, Avignon, Besançon, Bordeaux, Challes-les-Eaux
2023-10-11
Active, closed
AbbVie
Phase 3
1,328
Nice, Bordeaux, Reims, Nantes, Lyon, Antony
2023-06-21
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Angers, Antony, Bordeaux, Brest, Montpellier, Nice, Paris, Pierre-Bénite
2022-12-09
Active, closed
Biogen
Phase 2/3
450
Nice, Marseille, Caen, Besançon, Toulouse, Antony, Montpellier, Lille
2022-09-13
Active, closed
Sanofi
Phase 2/3
1,856
Antony, Bordeaux, Clermont-Ferrand, Créteil, Lille, Nice, Reims, Rouen
2022-08-22
Active, closed
BeOne Medicines
Phase 3
799
Antony, Le Mans, Montpellier, Nice, Paris, Strasbourg, VandoeuvrelesNancy
2022-03-10
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Observational
180
Antony, Paris
2022-02-14
Active, closed
Intergroupe Francophone de Cancerologie Thoracique
Phase 2
54
Aix-en-Provence, Angers, Annecy, Antony, Avignon, Bayonne, Bordeaux, Boulogne
2021-03-19
Active, closed
Pfizer
Phase 3
1,068
Antony, Bayonne, Bordeaux, Brest, Limoges, Nancy, Paris, Strasbourg
2019-12-30
Active, closed
Sanofi
Observational
955
Antony, Bordeaux, Montpellier, Pierre-Bénite, Rouen, Saint-Mandé Cedex, Toulouse, Valence
2019-06-11
Recruiting
Pathophysiological Explorations of Red Blood Cells
NCT03541525Red Blood Cell Disorder
Imagine Institute
Observational
3,750
Amiens, Antony, Bobigny, Bordeaux, Clichy, Colombes, Créteil, Le Kremlin-Bicêtre
2017-10-16
Recruiting
Federation Francophone de Cancerologie Digestive
Phase 3
348
Angers, Antony, Avignon, Bayonne, Beauvais, Bordeaux, Caluire-et-Cuire, Challans
2016-12
Rows per page Showing 1–29 of 29
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-france/city/antony

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,714 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 29 of those studies with a site in Antony.

How many clinical trials are recruiting in Antony?

13 of the 29 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 15 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Antony), 29 studies
PhaseStudiesRecruitingShare
Phase 311437.9%
Observational8527.6%
Phase 24113.8%
Not applicable3310.3%
Phase 2/3206.9%
Phase 1/2103.4%

Most active sponsors

Lead sponsors with the most studies (Antony)
Lead sponsorStudiesRecruiting
Sanofi41
Federation Francophone de Cancerologie Digestive32
Novartis Pharmaceuticals30
Incyte Corporation21
AbbVie10
AstraZeneca10
BeOne Medicines10
Biogen10
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company11
Fondation Ellen Poidatz11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.